Ketamine raises blood pressure and heart rate in most people, but the effect is temporary and usually modest at clinical doses. A meta-analysis of psychiatric-dose studies found an average systolic blood pressure increase of about 13 mmHg and a heart rate bump of roughly 4 beats per minute, both of which resolve within an hour or two of the dose ending.1Frontiers in Psychiatry. Meta-Analysis: Hemodynamic Responses to Sub-anesthetic Doses of Ketamine in Patients With Psychiatric Disorders That profile makes ketamine unusual among sedatives and anesthetics, most of which lower blood pressure. The cardiovascular story gets more complicated when you consider who is receiving the drug, how much, and for how long.
What Happens to Blood Pressure and Heart Rate
Ketamine’s signature cardiovascular fingerprint is a rise in both blood pressure and heart rate. The drug stimulates the sympathetic nervous system, the body’s “fight or flight” wiring, which releases norepinephrine and drives up vascular tone. Across pooled data from psychiatric-dose trials, systolic pressure climbed an average of about 13 mmHg and diastolic pressure about 8.5 mmHg, with heart rate increasing around 4 beats per minute.1Frontiers in Psychiatry. Meta-Analysis: Hemodynamic Responses to Sub-anesthetic Doses of Ketamine in Patients With Psychiatric Disorders These changes peak somewhere around 30 to 40 minutes after the dose begins, then fade as the drug is cleared.
Interestingly, ketamine also has a direct relaxing effect on blood vessel smooth muscle at higher concentrations, which partially offsets the sympathetic stimulation. Lab studies on isolated arteries show that at lower concentrations ketamine slightly enhances the squeeze of norepinephrine on vessel walls, while at higher concentrations it inhibits that contraction by blocking calcium entry into muscle cells.2Anesthesiology. Mechanisms of Direct Inhibitory Action of Ketamine on Vascular Smooth Muscle in Mesenteric Resistance Arteries The net result in a living patient depends on the balance between central sympathetic drive and local vessel relaxation. In people whose sympathetic reserves are depleted, say from severe illness or spinal cord injury, the direct relaxing effect can dominate, and blood pressure may not rise at all. One study in intensive care patients with brain or spinal cord injuries found that ketamine did not change any hemodynamic variables.3British Journal of Anaesthesia. Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury
Ketamine also increases cardiac output in healthy volunteers, essentially pushing more blood through the circulation per minute. A pharmacokinetic modeling study in healthy adults confirmed this, though it also found that S-norketamine, a metabolite of the S-form of the drug, actually decreases cardiac output, creating a time-dependent push and pull as the drug is metabolized.4British Journal of Anaesthesia. Stereoselective ketamine effect on cardiac output: a population pharmacokinetic/pharmacodynamic modelling study in healthy volunteers
Blood Pressure During Low-Dose Infusions for Depression
The growing use of ketamine to treat depression has generated a large body of data on what happens to blood pressure when the drug is given at sub-anesthetic doses, typically 0.5 mg per kilogram infused over 40 minutes. In this setting, the blood pressure rises are smaller than the pooled meta-analytic averages might suggest, because many of those pooled studies include higher psychiatric doses and varied protocols. A report covering 684 infusions found peak systolic increases averaging only about 3 mmHg at the 30-minute mark, with values returning to baseline during post-infusion monitoring.5PubMed. Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions A separate study of repeated infusions in depressed patients reported somewhat higher peaks, with the largest mean systolic increase around 7.4 mmHg, still returning to normal after the infusion stopped.6PubMed. Cardiovascular effects of repeated subanaesthetic ketamine infusion in depression
People who already have high blood pressure tend to have higher peak values during infusions, which makes sense since they are starting from a higher baseline.5PubMed. Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions That does not mean hypertensive patients cannot receive ketamine, but it does mean closer monitoring is warranted. For intranasal esketamine (the S-enantiomer approved as Spravato), the clinical development program found that blood-pressure-related side effects occurred in about 13% of patients, with peaks within 40 minutes and values returning to pre-dose ranges by roughly an hour and a half.7PubMed Central. Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program The overall cardiovascular safety profile was described as transient and manageable.
Concerns for People with Heart Disease
The reassuring data from depression clinics applies mainly to people with relatively healthy hearts. In patients with ischemic heart disease, ketamine’s effects look different. Because the drug raises heart rate and blood pressure, it increases the heart’s demand for oxygen at the very moment when diseased coronary arteries may not be able to deliver it. An echocardiography study in patients with ischemic heart disease found that heart rate jumped about 34% and blood pressure about 35% after ketamine, while left ventricular systolic function actually declined, and diastolic relaxation worsened.8PubMed. Ketamine reduce left ventricular systolic and diastolic function in patients with ischaemic heart disease In plain terms, the heart was working harder and pumping less effectively.
A small procedural sedation study found new signs of ischemia on the electrocardiogram in about 10% of adult patients who received ketamine, though these findings did not change patient outcomes or hospital disposition.9Cureus. Effect of Ketamine on Cardiovascular Function During Procedural Sedation of Adults The numbers are small enough that firm conclusions are difficult, but the pattern is consistent with the idea that ketamine can stress a vulnerable heart.
Arrhythmia and the Electrical Side
Ketamine’s effects on heart rhythm have historically been considered benign at clinical doses, but case reports have raised new questions. A recently published case described what appears to be the first documented instance of ketamine-induced torsades de pointes, a dangerous type of heart rhythm disturbance linked to a prolonged QT interval on the ECG. The report notes that prior trials had already observed QTc prolongation when ketamine was combined with propofol during cardiac surgery.10Heart Rhythm Case Reports. Ketamine with a twist: the first reported case of ketamine-induced torsades de pointes The authors were cautious about drawing firm causation from a single case, but the finding is a flag for clinicians, particularly in patients who already have risk factors for QT prolongation such as electrolyte imbalances or use of other QT-prolonging drugs.
Pulmonary Blood Pressure
Whether ketamine raises pressure in the lung’s blood vessels has been debated for decades, and the answer depends heavily on the patient population studied. An older study of adults with valvular heart disease found that pulmonary vascular resistance jumped dramatically, by more than 150%, after ketamine, leading the authors to warn against its use in patients with limited right-heart reserve.11PubMed. The cardiovascular effects of ketamine used for induction of anaesthesia in patients with valvular heart disease That early finding became entrenched as conventional teaching and discouraged use of ketamine in anyone with pulmonary hypertension.
More recent pediatric data, however, tells a much milder story. A study of children with pulmonary hypertension found that mean pulmonary artery pressure increased by just 2 mmHg after ketamine, a change that was statistically measurable but clinically insignificant. Pulmonary vascular resistance did not change significantly, and severity of existing pulmonary hypertension did not make the response worse.12PubMed. Hemodynamic response to ketamine in children with pulmonary hypertension Another pediatric abstract similarly concluded that ketamine does not increase pulmonary vascular resistance in children with pulmonary hypertension.13Pediatric Critical Care Medicine. Proceedings of the 2005 Pediatric Cardiac Intensive Care Symposium: Abstracts The gap between the older adult valvular data and the newer pediatric data likely reflects differences in patient populations, dosing, and concurrent medications. Many clinicians now consider the blanket prohibition on ketamine in pulmonary hypertension to be outdated, at least in the pediatric setting.
Children with Congenital Heart Disease
Ketamine’s hemodynamic friendliness in children extends beyond pulmonary hypertension. A study specifically examining children with congenital heart defects, including those with pulmonary hypertension, concluded that ketamine at usual clinical doses has minimal impact on hemodynamics. Systemic and pulmonary vascular resistance were not significantly altered, and blood gas values barely changed.14PubMed. Hemodynamic effects of ketamine in children with congenital heart disease and/or pulmonary hypertension An older cardiac catheterization study in children with congenital heart disease found statistically significant but clinically minor bumps in heart rate and mean pulmonary artery pressure, with no significant changes in systemic blood pressure or arterial oxygen levels, and no major adverse events.15PubMed. Hemodynamic effects of ketamine in children with congenital heart disease These findings have made ketamine a commonly used sedation agent for pediatric cardiac procedures.
Why Emergency Physicians Like Ketamine
Most sedatives and induction agents used to put patients to sleep for emergency intubation lower blood pressure, sometimes dangerously so in patients who are already hemodynamically unstable from trauma, sepsis, or blood loss. Ketamine’s blood-pressure-supporting properties make it attractive in exactly those situations. A large emergency department study found that ketamine use was associated with roughly half the odds of post-intubation hypotension compared to other agents in hemodynamically unstable patients.16Scientific Reports. Association of ketamine use with lower risks of post-intubation hypotension in hemodynamically-unstable patients in the emergency department That advantage held regardless of how unstable the patient was before intubation.
A helicopter emergency medical services study comparing ketamine to etomidate, another agent often chosen for its hemodynamic stability, found that etomidate patients experienced 25 episodes of post-administration hypotension compared to just two in the ketamine group.17The Journal of Emergency Medicine. Hemodynamics in Helicopter Emergency Medical Services Patients Undergoing Rapid Sequence Intubation With Etomidate or Ketamine In the intensive care unit, ketamine used as a continuous sedation drip produced significantly less hypotension and bradycardia than propofol or dexmedetomidine, with the alternative agents carrying more than three times the odds of a negative hemodynamic event.18PubMed. Hemodynamic Effects of Ketamine Compared With Propofol or Dexmedetomidine as Continuous ICU Sedation A separate comparison of propofol-plus-ketamine versus propofol-plus-etomidate for anesthesia induction in elderly patients found no hemodynamic difference between the two combinations, suggesting that adding ketamine to a standard regimen does not worsen stability.19PubMed Central. Hemodynamic Stability during Induction of Anesthesia in Elderly Patients: Propofol + Ketamine versus Propofol + Etomidate
In patients who are already in shock, though, there is an important caveat. When someone’s sympathetic nervous system is already running at maximum capacity to maintain blood pressure, ketamine cannot squeeze out much more sympathetic tone. In that scenario one study found that post-intubation hypotension rates with ketamine were similar to those with etomidate, around 30-33%.20PubMed Central. Ketamine Is Not Associated With More Post-Intubation Hypotension Than Etomidate In Patients Undergoing Endotracheal Intubation Ketamine is still not worse than the alternative, but its advantage narrows in the sickest patients.
Long-Term Abuse and Cardiac Damage
Ketamine’s cardiovascular profile in acute, medically supervised settings is reasonably well characterized. What happens with chronic recreational abuse is grimmer and less studied, but the available evidence is concerning. Animal research has shown that chronic ketamine exposure causes structural damage to heart muscle, including cell death, scarring, and abnormal nerve sprouting in the ventricles. These changes altered the heart’s electrical properties and made it more vulnerable to dangerous arrhythmias, a pathway that could explain reports of sudden cardiac death in long-term ketamine users.21PubMed Central. Ketamine-induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol
A separate mouse study examining long-term ketamine exposure found elevated blood levels of troponin (a marker released when heart muscle cells are damaged), increased activity of a damage-associated enzyme in heart tissue, and abnormal electrical patterns on ECG including ST elevation and premature ventricular beats.22Toxicology Letters. Cardiotoxicity induced in mice by long term ketamine and ketamine plus alcohol treatment Combining ketamine with alcohol made the damage worse. These are animal models, so direct translation to human recreational users requires caution, but the consistency of the findings across different labs and endpoints is notable. Chronic ketamine abuse is already known to devastate the bladder; the heart may be a less-recognized but equally important organ at risk.
Who Should Be Cautious
Published safety reviews describe several cardiovascular conditions that have traditionally been treated as contraindications for ketamine. These include uncontrolled high blood pressure, unstable angina or recent heart attack, significant valve disease, aortic or cerebral aneurysms, and moderate-to-severe heart failure.23Frontiers in Psychiatry. Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management Standard practice calls for a physical exam confirming stable vital signs before ketamine administration, and patients with significant medical complexity may need formal anesthesia consultation.24PubMed Central. Safety considerations and risk mitigation strategies for ketamine use: a comprehensive review
There is an active debate, however, about whether these should be absolute contraindications or relative ones weighed case by case. People with severe depression often have undertreated high blood pressure and cardiovascular disease. Excluding them rigidly from ketamine treatment may deny them a potentially life-saving antidepressant while applying a standard that is stricter than what is used for electroconvulsive therapy, where patients receive full general anesthesia with its own cardiovascular stresses. Some experts argue that elevated blood pressure alone should not necessarily rule out ketamine, particularly when the alternative is leaving severe depression untreated.23Frontiers in Psychiatry. Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
A Paradox in the Lab
The sympathetic stimulation ketamine produces is its most prominent cardiovascular effect, and it is largely responsible for the clinical precautions described above. Yet underneath that stimulation, laboratory research has uncovered a surprisingly protective side. In a rat model of type 2 diabetes, ketamine combined with insulin protected heart tissue from injury during ischemia-reperfusion, the kind of damage that occurs when blood flow is cut off and then restored, as happens during a heart attack or cardiac surgery. The mechanism appeared to involve regulation of autophagy, the cellular cleanup process that goes haywire during reperfusion.25PubMed Central. Ischemia reperfusion myocardium injuries in type 2 diabetic rats: Effects of ketamine and insulin on LC3-II and mTOR expression Animal studies in the chronic-abuse setting found that the beta-blocker metoprolol could prevent some of the structural heart damage ketamine caused, hinting at potential mitigation strategies if chronic exposure is unavoidable.21PubMed Central. Ketamine-induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol And ketamine’s peripheral autonomic effects include dose-dependent depression of the sympathetic outflow measured at the spinal level, a mechanism that may partly explain why its blood-pressure effects are self-limiting at moderate doses.26PubMed Central. Effects of ketamine on the peripheral autonomic nervous system of the rat None of this translates into a clinical recommendation yet, but it illustrates that ketamine’s relationship with the heart is more nuanced than a simple “it raises your blood pressure.” The drug simultaneously pushes and pulls on the cardiovascular system through multiple pathways, and which effect dominates depends on the dose, the patient’s underlying physiology, and how long the exposure lasts.